IceCure Medical Ltd.
ICCM- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001584371
No open-market purchases or sales by IceCure Medical Ltd. insiders were filed in the last 90 days; 11 institutions reported holding it in 13F filings for Q2 2026, worth $544.7K in total; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, −7 vs. previous quarter
- 11
- 13F valueReported value at the end of Q2 2026
- $544.7K
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding ICCM, Q2 2026
No superinvestor reported holding ICCM at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by IceCure Medical Ltd. insiders from Form 4, newest first.
No open-market purchases or sales by IceCure Medical Ltd. insiders are on file.
Top 10 13F holders, Q2 2026
The largest institutional positions in IceCure Medical Ltd. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Jane Street Group, LLC | 34,885 | $169.5K | 0.00% | +34,885 | New |
| Scientech Research LLC | 32,696 | $158.9K | 0.13% | +32,696 | New |
| UBS Group AG | 17,093 | $83.1K | 0.00% | −137,105−88.9% | Reduced |
| HRT Financial LP | 15,151 | $73.0K | 0.00% | −32,445−68.2% | Reduced |
| JPMorgan Chase & Co | 5,950 | $31.3K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 4,334 | $21.1K | 0.00% | −12,666−74.5% | Reduced |
| Gunderson Capital Management Inc. | 20,000 | $3.03K | 0.00% | 00.0% | Unchanged |
| Kingdom Financial Group LLC. | 533 | $2.59K | 0.00% | −15,467−96.7% | Reduced |
| SBI Securities Co., Ltd. | 451 | $2.19K | 0.00% | +442+4,911.1% | Added |
| Bartlett & Co. Wealth Management LLC | 8 | $39 | 0.00% | −242−96.8% | Reduced |